novo nordisk wegovy weight loss

These Drugs Could Offset Side Effects of Weight Loss

Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs

Novo Nordisk shares rose Wednesday after fourth-quarter earnings beat Wall Street's estimates, 2025 forecast came in line with expectations. Novo CEO Lars Fruergaard Jorgensen sees Wegovy supply improving this year,

New York Post on MSN · 1d

Next Generation Weight Loss Drugs Aim to Save Muscle

Some doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures. A higher portion of muscle can also help patients keep weight off for longer, experts say.

Inc · 1d

These Drugs Could Offset the Side Effects of Weight Loss

Reuters on MSN · 1d

Fat, not muscle: drugmakers in race for next weight-loss breakthrough

Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss that can increase the risk of falls and decrease overall strength,

The Motley Fool18d

Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands

In a 72-week study, Zepbound's mean weight loss was 20.2%, while Wegovy's was 13.7%. Amycretin did better in half the time. Novo Nordisk faces at least two issues in the anti-obesity space.

pharmaphorum4d

Novo Nordisk says oral Wegovy hits weight loss goal

Novo Nordisk has struck back in its growing rivalry with Eli Lilly in the obesity market, with data showing a higher-dose version of its oral version of weight loss drug Wegovy hit the mark ...

WRAL15d

Weight loss pill could replace injections, would be transformative for millions

A breakthrough in weight loss medication is on the horizon. While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

15don MSN

Novo Nordisk beats on Wegovy sales, expects slower 2025 growth

Danish drugmaker Novo Nordisk reported fourth quarter and full year 2024 earnings Wednesday, beating Wall Street's ...

14hon MSN

From pills to new uses, here's what Eli Lilly's top scientist sees as the future of weight loss drugs

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Are Weight Loss Injections Safe? What to Know Before Starting One

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results